Current filters:  
United States
Healthcare
United States
Foley & Lardner
In its November 2023 Proposed Rule and in its recently issued Final Rule that was published in the Federal Register on April 23, 2024, the Centers for Medicare & Medicaid Services (CMS)...
Goodwin Procter LLP
On April 15, 2024, Fresenius Kabi announced the U.S. launch of its ACTEMRA biosimilar, TYENNE (tocilizumab-aazg) as an intravenous formulation.
Crowell & Moring LLP
The Federal Trade Commission (FTC) recently entered into a settlement with Monument, Inc., an alcohol addiction treatment service, ...
Exponent
On March 15, the Food and Drug Administration issued new draft guidance that impacts premarket submissions for all medical devices that produce temperature changes in patient tissues...
Mintz
The government's continued dedication of resources to investigating and prosecuting fraud against COVID-19 pandemic relief programs appears to have borne fruit according to the results of the COVID-19 ...
Holland & Knight
In this episode of "Counsel That Cares," healthcare attorney Jesse Neil examines the unique challenges and strategic options facing public hospitals...
Perkins Coie LLP
The Washington State Supreme Court significantly expanded the scope of potential hospital tort liability for the allegedly negligent actions of nonemployee, independently contracted emergency room service physicians...
Exponent
On Nov. 17, the Food and Drug Administration released the final guidance for assessing the credibility of computational modeling and simulation (CM&S) in medical device submissions.
Jones Day
In February 2024, the Department of Justice ("DOJ") announced the results of its 2023 False Claims Act ("FCA") enforcement efforts.
Holland & Knight
"Informed consent" has been described as "a bedrock principle of healthcare in a free society," and if a "patient is denied the ability to exercise or even consider informed consent, the patient's personal liberty suffers."
Exponent
Updates on conducting a toxicological risk assessment of medical device extractable and leachable constituents for FDA submissions
Exponent
Four questions for developing inclusive digital solutions by identifying women-specific requirements and endpoints
Bass, Berry & Sims
The Bass, Berry & Sims Healthcare Private Equity Team is pleased to share with you our first installment of the BBS Connect Newsletter for 2024.
Ankura Consulting Group LLC
The Health Insurance Portability and Accountability Act (HIPAA) mandates stringent protections for the privacy and security of protected health information (PHI).
Sheppard Mullin Richter & Hampton
Parties involved in or considering health care transactions in California have been focused on navigating the new rules set by California's Office of Health Care Affordability (OHCA)...
Farrell Fritz, P.C.
We live in an age of scientific miracles. We have an unprecedented ability to identify the causes of disease, and we have access to treatments, and even cures, we could not imagine only a few decades ago.
Ankura Consulting Group LLC
In 2023, U.S. pet industry spending reached $143.6 billion, reflecting over two decades of growth and resilience against economic downturns.
Sheppard Mullin Richter & Hampton
Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health-tech topics and trends of the day.
Dickinson Wright PLLC
One of the most popular incentives for service industry employees is the "Shift Drink" – a drink on the house to unwind after a work day.
Holland & Knight
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Popular Authors
Mondaq Social Media